AI assistant
MEDIFAST INC — Director's Dealing 2022
Aug 10, 2022
33899_dirs_2022-08-10_4d5a6b05-5ef4-4846-af53-12f39dfde5ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-08-08
Reporting Person: BROWN JEFFREY J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-08 | Common Stock | A | 9.040 | $138.78 | Acquired | 2354.040 | Direct |
| 2022-08-04 | Common Stock | P | 399.162 | $146.0144 | Acquired | 35937.85 | Indirect |
Footnotes
F1: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
F2: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.